Home Indiana Agriculture News Bayer Focused on Defending Glyphosate

Bayer Focused on Defending Glyphosate

SHARE

Bayer says that it’s focused on defending Monsanto weed-killers containing glyphosate from lawsuits over claims that the products cause cancer. However, Bayer CEO Werner Baumann says they might settle those cases if the court costs become too high. Earlier this year, Bayer acquired Monsanto for $63 billion. “If we can settle nuisances at some point where the defense costs become significantly higher than potential settlement amounts, we will of course consider it from an economic standpoint,” says Baumann.

A Reuters report says that was his response to questions on whether or not Bayer might consider settling in certain scenarios. He did add that, “We will resolutely and with all means defend ourselves against this glyphosate litigation.”

The California groundskeeper who won a lawsuit against Bayer’s Monsanto by claiming that Roundup herbicide caused his cancer has agreed to accept $78 million dollars. He’s doing so against the advice of his lawyers because he wants to “ensure that the situation is resolved in his lifetime.” The jury’s initial reward in the case was $289 million, later reduced to $78 million by a judge. .

Dewayne Johnson was a California groundskeeper and pest-control manger, age 42, who developed a strange rash that would lead to a diagnosis of non-Hodgkin’s lymphoma. Court records say his duties included mixing and spraying hundreds of gallons of Roundup, the company’s weed killer that contains glyphosate. Johnson’s doctors say he’s in the last stages of his life.

A Bayer Crop Science spokesperson issued a statement, saying, “The Court’s decision to reduce the punitive damages by more than $200 million is a step in the right direction. However, we believe the verdict and damage awards aren’t warranted or supported by the evidence available.” Bayer is planning to appeal the verdict to the California Court of Appeals.

Source: NAFB News Service